Topiramate Tablet, Film Coated
Product Images NDC 60760-752

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 60760-752). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by St. Mary's Medical Park Pharmacy, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (9df497de Be9f 4244 A769 A72a0e64dc42 01)

Chemical structure diagram of topiramate, showing its molecular arrangement including carbon, oxygen, sulfur, nitrogen, and hydrogen atoms organized in a complex ring and side groups.*

FDA Label Image

Image (9df497de Be9f 4244 A769 A72a0e64dc42 02)

A line graph depicting cumulative rates for time to first seizure over 500 days comparing two groups: one taking Topiramate 50 mg/day (N=234) and the other Topiramate 400 mg/day (N=236). The vertical axis shows cumulative seizure rates, and the horizontal axis shows time in days. A p-value of 0.0002 is noted on the graph.*

FDA Label Image

Image (9df497de Be9f 4244 A769 A72a0e64dc42 03)

A bar chart presenting the change from baseline to double-blind phase in average monthly migraine period rate (± SE) for placebo and topiramate at doses of 50 mg/day, 100 mg/day, and 200 mg/day. Data are shown for two studies, with both studies indicating statistically significant reductions in migraine rates at higher topiramate doses compared to placebo.*

FDA Label Image

Image (961973db B7ab 40fa Ad75 4163738def9b 565 2)

FDA Label Image

752 (Topiramate 25mg 30ct 60760 752 30)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.